PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
JRI vs. BSTZ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between JRI and BSTZ is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

JRI vs. BSTZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nuveen Real Asset Income and Growth Fund (JRI) and BlackRock Science and Technology Trust II (BSTZ). The values are adjusted to include any dividend payments, if applicable.

-5.00%0.00%5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
6.83%
19.22%
JRI
BSTZ

Key characteristics

Sharpe Ratio

JRI:

1.83

BSTZ:

1.35

Sortino Ratio

JRI:

2.41

BSTZ:

1.88

Omega Ratio

JRI:

1.34

BSTZ:

1.24

Calmar Ratio

JRI:

1.51

BSTZ:

0.60

Martin Ratio

JRI:

6.97

BSTZ:

5.77

Ulcer Index

JRI:

3.72%

BSTZ:

5.07%

Daily Std Dev

JRI:

14.23%

BSTZ:

21.70%

Max Drawdown

JRI:

-60.74%

BSTZ:

-59.31%

Current Drawdown

JRI:

-3.01%

BSTZ:

-28.44%

Fundamentals

Returns By Period

In the year-to-date period, JRI achieves a 7.73% return, which is significantly higher than BSTZ's 5.68% return.


JRI

YTD

7.73%

1M

4.39%

6M

6.66%

1Y

26.50%

5Y*

1.59%

10Y*

4.91%

BSTZ

YTD

5.68%

1M

0.05%

6M

17.57%

1Y

32.30%

5Y*

9.65%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

JRI vs. BSTZ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JRI
The Risk-Adjusted Performance Rank of JRI is 8787
Overall Rank
The Sharpe Ratio Rank of JRI is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of JRI is 8585
Sortino Ratio Rank
The Omega Ratio Rank of JRI is 8686
Omega Ratio Rank
The Calmar Ratio Rank of JRI is 8686
Calmar Ratio Rank
The Martin Ratio Rank of JRI is 8686
Martin Ratio Rank

BSTZ
The Risk-Adjusted Performance Rank of BSTZ is 7777
Overall Rank
The Sharpe Ratio Rank of BSTZ is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of BSTZ is 7777
Sortino Ratio Rank
The Omega Ratio Rank of BSTZ is 7474
Omega Ratio Rank
The Calmar Ratio Rank of BSTZ is 6969
Calmar Ratio Rank
The Martin Ratio Rank of BSTZ is 8383
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

JRI vs. BSTZ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Nuveen Real Asset Income and Growth Fund (JRI) and BlackRock Science and Technology Trust II (BSTZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for JRI, currently valued at 1.83, compared to the broader market-2.000.002.001.831.35
The chart of Sortino ratio for JRI, currently valued at 2.41, compared to the broader market-4.00-2.000.002.004.006.002.411.88
The chart of Omega ratio for JRI, currently valued at 1.34, compared to the broader market0.501.001.502.001.341.24
The chart of Calmar ratio for JRI, currently valued at 1.51, compared to the broader market0.002.004.006.001.510.60
The chart of Martin ratio for JRI, currently valued at 6.97, compared to the broader market0.0010.0020.0030.006.975.77
JRI
BSTZ

The current JRI Sharpe Ratio is 1.83, which is higher than the BSTZ Sharpe Ratio of 1.35. The chart below compares the historical Sharpe Ratios of JRI and BSTZ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.00SeptemberOctoberNovemberDecember2025February
1.83
1.35
JRI
BSTZ

Dividends

JRI vs. BSTZ - Dividend Comparison

JRI's dividend yield for the trailing twelve months is around 11.77%, more than BSTZ's 9.38% yield.


TTM20242023202220212020201920182017201620152014
JRI
Nuveen Real Asset Income and Growth Fund
11.77%11.85%9.19%9.95%7.22%9.09%7.05%9.33%7.21%8.58%10.37%14.83%
BSTZ
BlackRock Science and Technology Trust II
9.38%9.74%10.89%14.73%7.92%3.42%2.44%0.00%0.00%0.00%0.00%0.00%

Drawdowns

JRI vs. BSTZ - Drawdown Comparison

The maximum JRI drawdown since its inception was -60.74%, roughly equal to the maximum BSTZ drawdown of -59.31%. Use the drawdown chart below to compare losses from any high point for JRI and BSTZ. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-3.01%
-28.44%
JRI
BSTZ

Volatility

JRI vs. BSTZ - Volatility Comparison

The current volatility for Nuveen Real Asset Income and Growth Fund (JRI) is 3.02%, while BlackRock Science and Technology Trust II (BSTZ) has a volatility of 7.61%. This indicates that JRI experiences smaller price fluctuations and is considered to be less risky than BSTZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%SeptemberOctoberNovemberDecember2025February
3.02%
7.61%
JRI
BSTZ

Financials

JRI vs. BSTZ - Financials Comparison

This section allows you to compare key financial metrics between Nuveen Real Asset Income and Growth Fund and BlackRock Science and Technology Trust II. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab